Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

Botulinum Toxin Type A and Physiotherapy in Spasticity of the Lower Limbs Due to Amyotrophic Lateral Sclerosis.

Marvulli R, Megna M, Citraro A, Vacca E, Napolitano M, Gallo G, Fiore P, Ianieri G.

Toxins (Basel). 2019 Jul 1;11(7). pii: E381. doi: 10.3390/toxins11070381.

2.

Pain and muscles properties modifications after botulinum toxin type A (BTX-A) and radial Extracorporeal Shock Wave (rESWT) combined treatment.

Megna M, Marvulli R, Farì G, Gallo G, Dicuonzo F, Fiore P, Ianieri G.

Endocr Metab Immune Disord Drug Targets. 2019 Mar 5. doi: 10.2174/1871530319666190306101322. [Epub ahead of print]

PMID:
30843498
3.

"Appropriate Treatment" and Therapeutic Window in Spasticity Treatment with IncobotulinumtoxinA: From 100 to 1000 Units.

Ianieri G, Marvulli R, Gallo GA, Fiore P, Megna M.

Toxins (Basel). 2018 Mar 28;10(4). pii: E140. doi: 10.3390/toxins10040140.

4.

Efficacy and Non Invasive Treatment of Sialorrhea in the Goldenhar Syndrome.

Marvulli R, Gallo GA, Mastromauro L, Dicuonzo F, Fiore P, Ianieri G, Megna M.

Endocr Metab Immune Disord Drug Targets. 2018;18(4):397-400. doi: 10.2174/1871530318666180328122035.

PMID:
29595115
5.

Helping people in a minimally conscious state develop responding and stimulation control through a microswitch-aided program.

Lancioni GE, Singh NN, O'Reilly MF, Sigafoos J, D'Amico F, Buonocunto F, Navarro J, Lanzilotti C, Fiore P, Megna M, Damiani S, Marvulli R.

Eur J Phys Rehabil Med. 2017 Jun;53(3):433-440. doi: 10.23736/S1973-9087.16.04324-0. Epub 2016 Sep 1.

6.

Combined Treatment Fkt-Botulinum Toxin Type A (Btx-A) in Patients with Strumpell-Lorrain Disease.

Riccardo M, Angela L, Angela D, Vita P, Giulio L, Pietroq F, Giancarlo I, Marisa M.

Curr Pharm Des. 2016;22(6):758-63.

PMID:
26648460
7.

Use Of External Intrathecal Infusion Pumps In The Management Of Septic Complications: A Case Report.

Marvulli R, Chiumarulo P, Nisi M, Barulli L, Megna G, Pietro F, Ianieri G, Megna M.

Endocr Metab Immune Disord Drug Targets. 2015;15(4):293-6.

PMID:
25944064
8.

Objective Assessment of the Rheological Muscle Property in the Treatment of Fibromyalgia.

Marvulli R, Ianieri G, Mastromauro L, Romanelli E, Barulli L, Chiumarulo P, Megna G, Megna M.

Endocr Metab Immune Disord Drug Targets. 2015;15(3):229-33.

PMID:
25809192

Supplemental Content

Loading ...
Support Center